Aquestive Therapeutics (AQST) Reports Q4 Loss, Misses Revenue Estimates

Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.19 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -100.00%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of $0.13 per share when it actually produced a loss of $0.14, delivering a surprise of -7.69%.Over the last fou ...